Matchpoint Therapeutics raises $68.4M in its latest SEC filing
Matchpoint Therapeutics
- Raised in SEC filings
- $110.4M
- Filings
- 2
- Latest est. round
- Series B
- Incorporated
- 2021
- Industry
- Pharmaceuticals
- Based in
- MA
Matchpoint Therapeutics has filed 2 Form D offerings with the SEC. The latest reports $68.4M sold.
Every Form D filing
| First sale | Amount sold | Est. round |
|---|---|---|
| 2026-10-01 | $68.4M | Series B |
| 2022-10-05 | $42M | Series A |
Named in the latest filing
- Andre Turenne
- Brian Matesic
- Kanishka Pothula
- Jason Hafler
- Bruce Booth
- Daniel Becker
- Donald Nicolson
- Jared Cumming
- John O'Malley
From SEC Form D filings. Rounds are our estimate from the amount sold; filings carry no valuation. All filings on SEC EDGAR